Atlas Trials

Stage IV Renal Pelvis Cancer AJCC v8

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IV Renal Pelvis Cancer AJCC v8

RecordFirmDate
Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy (NCT04963153)National Cancer Institute (NCI)2022-07-07
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study (NCT05092958)National Cancer Institute (NCI)2022-06-03
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma (NCT04940299)M.D. Anderson Cancer Center2021-09-23
Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma (NCT04848519)Emory University2021-05-20
Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma (NCT03513952)National Cancer Institute (NCI)2019-06-05
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer (NCT03237780)National Cancer Institute (NCI)2018-07-20

Track Stage IV Renal Pelvis Cancer AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.